Metagenomi, Inc. Common Stock (MGX)
NASDAQ·Healthcare·Biotechnology
$1.14
-0.44%
Mkt Cap $60.07M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$14.50
Range $7.00 – $22.00
Implied Upside
+1177.5%
Consensus $14.50 vs current $1.14
NASDAQ·Healthcare·Biotechnology
$1.14
-0.44%
Mkt Cap $60.07M
No recent rating data.
Price Target (2 analysts)
$14.50
Range $7.00 – $22.00
+1177.5%
Consensus $14.50 vs current $1.14